A Find-and-Replace Approach to Fixing the Mutation Underlying Sickle Cell Disease
RARECast - Un pódcast de RARECast - Jueves
Categorías:
Josh Lehrer, CEO of Graphite Bio, discusses his company’s experimental sickle cell gene editing therapy, how it works, and what makes it a next-generation gene editor. @globalgenes #RARECast
